Since 1997, we have been constantly working to ensure that patients in our country have direct access to branded, innovative pharmaceutical products.
GENESIS' Pharma portfolio includes novel branded pharmaceutical products of high therapeutic value, many of which are biotech.
Most of these pharmaceutical products are intended exclusively for hospital use, and are designed to meet therapeutic needs of patients with rare and serious diseases.
HEMATOLOGY
ICLUSIG® (Ponatinib)
|
Incyte Biosciences UK Ltd |
IMNOVID® (Pomalidomide)
|
Celgene Europe Ltd
|
|
REVLIMID® (Lenalidomide)
|
Celgene Europe Ltd
|
|
THALIDOMIDE CELGENE® (Thalidomide)
|
Celgene Europe Ltd
|
|
VIDAZA® (Azacitidine)
|
Celgene Europe Ltd
|
ONCOLOGY
|
ABRAXANE® (nanoparticle albumin bound paclitaxel)
|
Celgene Europe Ltd
|
|
MEPACT® (Mifamurtide)
|
Takeda Ireland Ltd
|
|
YONDELIS® (Trabectedin)
|
PharmaMar SA
|
CENTRAL NERVOUS SYSTEM
|
AVONEX® (Interferon Beta-1a)
|
Biogen Idec Ltd
|
|
FAMPYRA® (Fampridine)
|
Biogen Idec Ltd
|
|
PLEGRIDY® (Peginterferon beta-1a)
|
Biogen Idec Ltd
|
TECFIDERA® (Dimethyl fumarate)
|
Biogen Idec Ltd |
TYSABRI® (Natalizumab)
|
Biogen Idec Ltd
|
NEPHROLOGY
|
VELPHORO® (Sucroferric oxyhydroxide)
|
Vifor Fresenius Medical Care Renal Pharma Ltd
|
| |
|
RHEUMATOLOGY
| OTEZLA® (Apremilast) |
Celgene Europe Ltd |
| |
|
DERMATOLOGY
|
OTEZLA® (Apremilast)
|
Celgene Europe Ltd
|
| |
|
IRON
|
FERINJECT® (Intravenous Iron Carboxymaltose)
|
Vifor France SA
|
|
FERRUM HAUSMANN® (Ferric hydroxide polymaltose complex)
|
GENESIS Pharma S.A.
|
|
FERRUM FOL HAUSMANN® (Ferric hydroxide polymaltose complex, folic acid)
|
GENESIS Pharma S.A.
|
|
|
|
Note: The companies listed on the right column refer to the Marketing Authorisation Holder of each product